Analyst Research

Report Title Price
MusclePharm Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
$20.00
Buy
MusclePharm Corp.: High Growth Prompts $12M Capital Raise
Provider: Streetwise Reports
$12.00
Buy
Biotech Micro Caps Offer Promise of Mighty Returns: Dick Huebner
Provider: Streetwise Reports
$58.00
Buy
Wright Investors Service Comprehensive Report for MusclePharm Corp
Provider: Wright Reports
$380.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

MusclePharm Corp Issues Q3, FY 2011 Revenue Guidance


Monday, 6 Feb 2012 12:00pm EST 

MusclePharm Corp announced that for the third quarter of 2011, it expects unaudited gross revenues of approximately $8,000,000. The Company also expects sales for fiscal 2011 to be approximately $21,000,000. 

Latest Developments for MusclePharm Corp

Latest Key Developments in Food

Company Quote

MusclePharm Corp
(MSLP.PK)
10.55
0.05 +0.48%
17 Jun 2013